Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AMPOWER A Single-arm, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of Phexxi™ (Previously Referred to as AMPHORA®) Contraceptive Vaginal Gel

NCT03243305 is registered in ClinicalTrials.gov with Evofem Inc. as lead sponsor.

NCT NCT03243305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03243305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AMPOWER A Single-arm, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of Phexxi™ (Previously Referred to as AMPHORA®) Contraceptive Vaginal Gel
Lead sponsor
Evofem Inc.
Phase
Phase 3
Overall status
Completed
Start date
July 24, 2017
Completion date
November 29, 2018
Enrollment
1,384 (actual)
Sites
87

Conditions

As the registry lists them; a condition with its own page is linked.

contraception